metastatic gastric cancer

Showing 1 - 25 of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

Not yet recruiting
  • Metastatic Cancer
  • +5 more
  • (no location specified)
Jul 10, 2023

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

Completed
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023

Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

Recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • Embolization
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 3, 2023

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Metastatic Gastric Cancer Trial in Zhengzhou (fruquintinib+toripalimab + SOX)

Recruiting
  • Metastatic Gastric Cancer
  • fruquintinib+toripalimab + SOX
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Aug 17, 2022

Metastatic Gastric Cancer, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Worldwide (Ramucirumab)

No longer available
  • Metastatic Gastric Cancer
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Ramucirumab
  • Graz, Austria
  • +43 more
Aug 17, 2022

Metastatic Gastric Cancer Trial in France (Phycocare, Placebo)

Recruiting
  • Metastatic Gastric Cancer
  • Phycocare
  • Placebo
  • Clermont-Ferrand, France
  • +7 more
Jul 8, 2022

Metastatic Gastric Cancer, Surgery, Chemo Trial (Palliative surgery after translational therapy, Chemotheraoy along)

Not yet recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • Palliative surgery after translational therapy
  • Chemotheraoy along
  • (no location specified)
Mar 30, 2022

Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION

Recruiting
  • Metastatic Cancer
  • +8 more
  • IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
  • Marseille, France
    Institut Paoli Calmettes
Feb 23, 2022

Metastatic Gastric Cancer Trial in Guangzhou (Irinotecan, Oxaliplatin, 5-fluorouracil)

Recruiting
  • Metastatic Gastric Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Jul 13, 2021

Metastatic Esophageal Cancer, Metastatic Gastric Cancer Trial in Sutton (Atezolizumab)

Recruiting
  • Metastatic Esophageal Cancer
  • Metastatic Gastric Cancer
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jul 12, 2021

Gastric Adenocarcinoma, Metastatic Gastric Cancer, Metastatic Adenocarcinoma Trial in France (Atezolizumab + Ipatasertib,

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Atezolizumab + Ipatasertib
  • Atezolizumab + Bevacizumab
  • Dijon, France
  • +8 more
Mar 26, 2021

Metastatic Gastric Cancer Trial in Anyang-si, Hwasun, Seoul (TEW-7197)

Unknown status
  • Metastatic Gastric Cancer
  • Anyang-si, Korea, Republic of
  • +5 more
Mar 17, 2021

Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction Trial in Amsterdam (Docetaxel, Oxaliplatin,

Active, not recruiting
  • Metastatic Gastric Cancer
  • Adenocarcinoma of the Gastro-oesophageal Junction
  • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab
  • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 26, 2021

Metastatic Gastric Cancer Trial in Wuhan (docetaxel)

Unknown status
  • Metastatic Gastric Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 8, 2020

Metastatic Gastric Cancer Trial in Philadelphia (Didactic Session, Comprehensive Geriatric Assessment, including an exploratory

Unknown status
  • Metastatic Gastric Cancer
  • Didactic Session
  • Comprehensive Geriatric Assessment, including an exploratory analysis to evaluate the use of fitness trackers for evaluation of functional status.
  • Philadelphia, Pennsylvania
  • +1 more
Nov 9, 2020

Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma Trial in Shanghai (Camrelizumab plus mFLOT regimen, R0

Unknown status
  • Metastatic Gastric Cancer
  • Locally Advanced Gastric Adenocarcinoma
  • Camrelizumab plus mFLOT regimen
  • R0 surgery
  • Shanghai, Shanghai, China
    Fudan University, Shanghai Cancer Center
Aug 11, 2020

Gastroesophageal Junction Adenocarcinoma, Stomach Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma Trial in

Unknown status
  • Gastroesophageal Junction Adenocarcinoma
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Feb 8, 2020

Metastatic Gastric Cancer Trial in Seoul (durvalumab, tremelimumab, paclitaxel)

Unknown status
  • Metastatic Gastric Cancer
  • durvalumab, tremelimumab, paclitaxel
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 2, 2019